Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424444
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-05-17
Brief Title:
A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Sponsor:
Aldeyra Therapeutics Inc
Organization:
Aldeyra Therapeutics Inc
Study Overview
Official Title:
A Multicenter Phase 3 Randomized Double-Masked Parallel-Group Vehicle-Controlled Environment Exposure Clinical Trial to Assess the Efficacy and Safety of 025 Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Multicenter Phase 3 Randomized Double-Masked Parallel-Group Vehicle-Controlled Environment Exposure Clinical Trial to Assess the Efficacy and Safety of 025 Reproxalap
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None